Collaborating On Common Challenges
The Think Tank on Advancing Precision Medicine in Rare Cancers is a highly interactive meeting that brings together clinicians, researchers, industry representatives, advocates, and patients to collaborate on common challenges in rare cancer research and treatment.
Leveraging the successful Think Tank model established through over a decade of TargetCancer Foundation meetings, it creates a collaborative environment where diverse perspectives and ideas thrive. This meeting also builds on the progress made through TargetCancer Foundation’s TCF-001 TRACK study, a nationwide, decentralized, patient-driven clinical trial studying precision medicine in rare cancers.
2024 Meeting Registration Is Now Open!
November 20, 2024 | State Room, Boston, MA
8:00 AM- 5:00 PM
Dinner reception to follow
Venue
The 2024 Think Tank on Advancing Precision Medicine in Rare Cancers will be held at the State Room in Boston, MA, located at 60 State Street. The venue is centrally located downtown and easily accessible via public transport.
Accommodations
We have secured a room block for attendees at The Bostonian Hotel for the nights of Tuesday, November 19 and Wednesday, November 20. We are pleased to offer a discounted rate of $179/night + tax. The Bostonian is a five-minute walk to the meeting venue.
Please click here to secure a room in our block.
This block will close on October 22, 2024.
2024 Steering Committee
Jennifer Levin Carter, MD, MPH, MBA
Medzown, Inc.
A. John Iafrate, MD, PhD
Massachusetts General Hospital
Harvard Medical School
Razelle Kurzrock, MD
Froedtert and Medical College
of Wisconsin
Thank You To Our Sponsors
What participants are saying
This was a fantastic #RareCancer #PrecisionMedicine meeting @targetcancer in Boston! So much enthusiasm from patients and patient advocates to move the field forward.
Vivek Subbiah, MD
Sarah Cannon Research Institute
Originally posted on Twitter
This is genuinely the best rare cancer meeting I have ever attended.
Razelle Kurzrock, MD
Froedtert and Medical College of Wisconsin
…thank you for allowing me to be a part of the discussion of challenges, goals, opportunities and best practices in addressing the needs of patients facing rare cancers. What a wonderful group of humans you gathered. I was so inspired.
Katie Ortman Doble
Patient Keynote Speaker,
2023 Think Tank on Advancing Precision Medicine in Rare Cancers
View and download materials from past meetings
TCF-001 TRACK Live Molecular Tumor Board 2023: Osteosarcoma
We are grateful to our industry partners for supporting these meetings and for their dedication to developing treatments for patients with rare cancers.
Join our Mailing List
TargetCancer Foundation
TargetCancer Foundation is a recognized 501(c)(3) charity, Tax ID 26-4510094.
All content and images copyright © 2024 TargetCancer Foundation. All rights reserved. | Privacy Policy